27Jan 2023
Randomized Trial of a Bionic Pancreas in Type 1 Diabetes

Randomized Trial of a Bionic Pancreas in Type 1 Diabetes

A clinical study reported significantly better glycemic control with a bionic pancreas than standard care in patients with type 1 diabetes. The trial included participants with a wide range of clinical, demographic, and economic characteristics. A benefit of the bionic pancreas compared with other semiautomated insulin-delivery systems is the simple initialization of therapy based on body weight so that training on the use of the device is minimal. Thus, such a device might be very effective in medically underserved patients or those not previously used.

  • #family health

Like

Save

Share